Receptor-targeted liposome-peptide-siRNA nanoparticles represent a novel and efficient therapeutic approach to prevent conjunctival fibrosis.

Cynthia Yu-Wai-Man, Aristides Tagalakis, Maria D. Manunta, M Bailly, Stephen L. Hart, Peng T. Khaw

Research output: Contribution to journalArticle (journal)peer-review

36 Citations (Scopus)
28 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Receptor-targeted liposome-peptide-siRNA nanoparticles represent a novel and efficient therapeutic approach to prevent conjunctival fibrosis.'. Together they form a unique fingerprint.

Medicine & Life Sciences